These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36360335)

  • 1. Increased Risk of Tourette Syndrome with Leukotriene Modifier Use in Children with Allergic Diseases and Asthma: A Nationwide Population-Based Study.
    Tsai ML; Lin HC; Yen CH; Ku JT; Sung SY; Chang H
    Children (Basel); 2022 Oct; 9(11):. PubMed ID: 36360335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukotriene antagonists reduce epileptic seizures-related hospitalization in older adult populations with allergic rhinitis or asthma: A population-based cohort study using the Shizuoka Kokuho database: The Shizuoka study.
    Imaichi Y; Nakatani E; Fukutomi Y; Kuriyama N; Mori K; Sugawara A
    Epilepsia Open; 2024 Feb; 9(1):200-209. PubMed ID: 37881138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients.
    Tsai MJ; Wu PH; Sheu CC; Hsu YL; Chang WA; Hung JY; Yang CJ; Yang YH; Kuo PL; Huang MS
    Sci Rep; 2016 Apr; 6():23979. PubMed ID: 27052782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychiatric Events Related to Montelukast and Pranlukast in Adults With Asthma and Rhinitis: A 10-Year Nationwide Population-Based Study.
    Jo YW; Kwon HS; Min J; Her Y; Kwon JW
    J Allergy Clin Immunol Pract; 2024 Sep; ():. PubMed ID: 39299666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cysteinyl Leukotriene Receptor Antagonists Associated With a Decreased Incidence of Cancer: A Retrospective Cohort Study.
    Jang HY; Kim IW; Oh JM
    Front Oncol; 2022; 12():858855. PubMed ID: 35463337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Neuropsychiatric Diseases According to the Use of a Leukotriene Receptor Antagonist in Middle-Aged and Older Adults with Asthma: A Nationwide Population-Based Study Using Health Claims Data in Korea.
    Shim JS; Kim MH; Kim MH; Cho YJ; Chun EM
    J Allergy Clin Immunol Pract; 2021 Dec; 9(12):4290-4297. PubMed ID: 34166842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukotriene receptor antagonists in allergic eye disease: a systematic review and meta-analysis.
    Gane J; Buckley R
    J Allergy Clin Immunol Pract; 2013 Jan; 1(1):65-74. PubMed ID: 24229824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukotriene Receptor Antagonist Use and Dementia Risk in Patients With Asthma: A Retrospective Cohort Study.
    Ishikura Y; Maeda-Minami A; Hosokawa M; Onoda A; Kawano Y; Ihara T; Sugamata M; Takeda K; Mano Y
    In Vivo; 2021; 35(6):3297-3303. PubMed ID: 34697161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship Between Leukotriene Receptor Antagonists on Cancer Development in Patients With Bronchial Asthma: A Retrospective Analysis.
    Maeda-Minami A; Hosokawa M; Ishikura Y; Onoda A; Kawano Y; Negishi K; Shimada S; Ihara T; Sugamata M; Takeda K; Mano Y
    Anticancer Res; 2022 Jul; 42(7):3717-3724. PubMed ID: 35790293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukotriene receptor antagonists and risk of neuropsychiatric events in children, adolescents and young adults: a self-controlled case series.
    Park JS; Cho YJ; Yun JY; Lee HJ; Yu J; Yang HJ; Suh DI;
    Eur Respir J; 2022 Nov; 60(5):. PubMed ID: 35595323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Montelukast does not increase the risk of attention-deficit/hyperactivity disorder in pediatric asthma patients: A nationwide population-based matched cohort study.
    Huang PY; Yang YH; Huang YH; Kuo HC; Wang LJ; Chien SJ; Chang LS
    J Formos Med Assoc; 2021 Jun; 120(6):1369-1376. PubMed ID: 33158697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukotriene Receptor Antagonists and Risk of Neuropsychiatric Entities: A Meta-Analysis of Observational Studies.
    Bai L; Xu Y; Pan T; Zhang Y; Zhou X; Xu J
    J Allergy Clin Immunol Pract; 2023 Mar; 11(3):844-854.e9. PubMed ID: 36473625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment persistence with leukotriene receptor antagonists and inhaled corticosteroids.
    Dorais M; Blais L; Chabot I; LeLorier J
    J Asthma; 2005 Jun; 42(5):385-93. PubMed ID: 16036414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of leukotriene receptor antagonists in asthma treatment and analysis of background factors evaluated by a questionnaire survey among physicians].
    Fukui Y; Hizawa N; Takahashi D; Maeda Y; Kobayashi M; Nasuhara Y; Nishimura M
    Nihon Kokyuki Gakkai Zasshi; 2008 Dec; 46(12):972-80. PubMed ID: 19195196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukotriene receptor antagonists as maintenance and intermittent therapy for episodic viral wheeze in children.
    Brodlie M; Gupta A; Rodriguez-Martinez CE; Castro-Rodriguez JA; Ducharme FM; McKean MC
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD008202. PubMed ID: 26482324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of montelukast in the treatment of asthma and allergic rhinitis.
    Nayak A
    Expert Opin Pharmacother; 2004 Mar; 5(3):679-86. PubMed ID: 15013935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of rheumatoid arthritis with allergic diseases: A nationwide population-based cohort study.
    Lai NS; Tsai TY; Koo M; Lu MC
    Allergy Asthma Proc; 2015; 36(5):99-103. PubMed ID: 26314811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlations of health-related quality of life questionnaire results in asthma and allergic rhinitis: effects of a leukotriene receptor antagonist.
    Ichimaru Y; Kanazawa H; Kamoi H; Kyoh S; Tochino Y; Kodama T; Hirata K
    J Int Med Res; 2008; 36(3):559-66. PubMed ID: 18534139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asthma pharmacotherapy: an update on leukotriene treatments.
    Trinh HKT; Lee SH; Cao TBT; Park HS
    Expert Rev Respir Med; 2019 Dec; 13(12):1169-1178. PubMed ID: 31544544
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of leukotriene receptor antagonists are associated with a similar risk of asthma exacerbations as inhaled corticosteroids.
    Wu AC; Li L; Fung V; Kharbanda EO; Larkin EK; Vollmer WM; Butler MG; Miroshnik I; Rusinak D; Davis RL; Hartert T; Weiss ST; Lieu TA
    J Allergy Clin Immunol Pract; 2014; 2(5):607-13. PubMed ID: 25213056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.